Judy Blumstock is the Founder and CEO of Diamond Therapeutics, a company focused on developing non-hallucinogenic psychedelic treatments for mental health. An MBA from Columbia Business School, she has over two decades of experience in commercializing life science innovations, particularly from academic institutions.
She is a vocal advocate for advancing mental health treatment and encourages public participation in research on attitudes toward psychedelics. Judy also actively supports community causes, such as fundraising for pediatric neurodevelopment research through organizations like the Sickkids Foundation.
Unique fact: She is pioneering the use of low-dose psilocybin to create accessible mental health therapies without hallucinogenic effects.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.